Lisa Ehlers
Overview
Explore the profile of Lisa Ehlers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goetzke C, Massoud M, Frischbutter S, Guerra G, Ferreira-Gomes M, Heinrich F, et al.
Nature
. 2025 Mar;
PMID: 40074901
In a subset of children and adolescents, SARS-CoV-2 infection induces a severe acute hyperinflammatory shock termed multisystem inflammatory syndrome in children (MIS-C) at four to eight weeks after infection. MIS-C...
2.
Ehlers L, Meyts I
J Allergy Clin Immunol
. 2025 Feb;
PMID: 39956283
Ten years after the description of the first cohorts of patients with adenosine deaminase (ADA2) deficiency (DADA2), the pathomechanisms underlying the disease on a cellular level remain poorly understood. With...
3.
Wouters M, Ehlers L, Van Eynde W, Kars M, Delafontaine S, Kienapfel V, et al.
medRxiv
. 2024 Dec;
PMID: 39711711
Human ADA2 deficiency (DADA2) is an inborn error of immunity with a broad clinical phenotype which encompasses vasculopathy including livedo racemosa and lacunar strokes, as well as hemato-immunological features. Diagnosis...
4.
Wouters M, Ehlers L, Dzhus M, Kienapfel V, Bucciol G, Delafontaine S, et al.
Curr Allergy Asthma Rep
. 2024 Jul;
24(9):477-484.
PMID: 38970744
In this review, an update is provided on the current knowledge and pending questions about human adenosine deaminase type 2 deficiency. Patients have vasculitis, immunodeficiency and some have bone marrow...
5.
Delafontaine S, Iannuzzo A, Bigley T, Mylemans B, Rana R, Baatsen P, et al.
J Clin Invest
. 2024 Jan;
134(4).
PMID: 38175705
Mutations in the N-terminal WD40 domain of coatomer protein complex subunit α (COPA) cause a type I interferonopathy, typically characterized by alveolar hemorrhage, arthritis, and nephritis. We described 3 heterozygous...
6.
Rodrigo Riestra M, Pillay B, Willemsen M, Kienapfel V, Ehlers L, Delafontaine S, et al.
J Clin Immunol
. 2023 Dec;
44(1):2.
PMID: 38099988
The DNA polymerase δ complex (PolD), comprising catalytic subunit POLD1 and accessory subunits POLD2, POLD3, and POLD4, is essential for DNA synthesis and is central to genome integrity. We identified,...
7.
Ehlers L, Rolfes E, Lieber M, Muller D, Lainka E, Gohar F, et al.
Pediatr Rheumatol Online J
. 2023 Sep;
21(1):108.
PMID: 37752496
Background: The objective of this initiative was to develop a treat-to-target (T2T) approach for the management of patients with Familial Mediterranean Fever (FMF), including the definition of a complex treatment...
8.
Hysa E, Bond M, Ehlers L, Camellino D, Falzon L, Dejaco C, et al.
Rheumatology (Oxford)
. 2023 Sep;
63(2):285-297.
PMID: 37672017
Objectives: To inform an international task force about current evidence on Treat to Target (T2T) strategies in PMR and GCA. Methods: A systematic literature research (SLR) was conducted in Medline,...
9.
Dzhus M, Ehlers L, Wouters M, Jansen K, Schrijvers R, De Somer L, et al.
J Clin Immunol
. 2023 Aug;
43(8):1916-1926.
PMID: 37548813
Deficiency of human adenosine deaminase type 2 (DADA2) is a complex systemic autoinflammatory disorder characterized by vasculopathy, immune dysregulation, and hematologic abnormalities. The most notable neurological manifestations of DADA2 are...
10.
Dejaco C, Kerschbaumer A, Aletaha D, Bond M, Hysa E, Camellino D, et al.
Ann Rheum Dis
. 2023 Feb;
83(1):48-57.
PMID: 36828585
Objectives: To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR). Methods: A systematic literature review was conducted to retrieve data on treatment targets and outcomes...